Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests-Reference-Cited by-同舟云学术

Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests

Published:2019-11-20 Issue:1 Volume:95 Page:117-128
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Favaloro Emmanuel J.¹^ORCID

Affiliation:

1. Department of HaematologyInstitute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, NSW Health Pathology, Westmead Hospital Westmead New South Wales Australia

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25669

Reference38 articles.

1. Overview of Hemostasis and Thrombosis and Contribution of Laboratory Testing to Diagnosis and Management of Hemostasis and Thrombosis Disorders

2. Recombinants in Thrombosis and Hemostasis: From Basic Research to Clinical Therapy

3. How to Generate a More Accurate Laboratory-Based International Normalized Ratio: Solutions to Obtaining or Verifying the Mean Normal Prothrombin Time and International Sensitivity Index

4. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors

5. Reference ranges in hemostasis testing: necessary but imperfect

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Council for Standardization in Haematology (ICSH) recommendations for the performance and interpretation of activated partial thromboplastin time and prothrombin time mixing tests;International Journal of Laboratory Hematology;2024-07-15

2. Discovery of TRPA1 Antagonist GDC-6599: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory Disease;Journal of Medicinal Chemistry;2024-03-03

3. Testing for the lupus anticoagulant: the good, the bad, and the ugly;Research and Practice in Thrombosis and Haemostasis;2024-03

4. In vitro differential inhibition of the factor XI activity assay in the setting of a lupus anticoagulant;Blood Coagulation & Fibrinolysis;2024-02-14

5. Coagulation Testing in Real-World Setting: Insights From a Comprehensive Survey;Clinical and Applied Thrombosis/Hemostasis;2024-01